相关实验视频
Updated: Jul 19, 2026

18:11
Microfluidic Chips Controlled with Elastomeric Microvalve Arrays
Published on: October 1, 2007
21.0K
用高性能材料优化微流体通道设计,为安全的新生儿药物输送提供高性能材料
T Archana1, N Nachammai1, S Praveenkumar2
1Department of Electronics and Instrumentation Engineering, Annamalai University, Annamalai Nagar, Chidambaram, India.
Recent advances in drug delivery and formulation
|October 2, 2024
概括
这项研究评估了用于新生儿药物输送的材料和微流体通道设计,发现PDMS是可行的解决方案. 优化的设计提高了药物输送效率和新生儿的安全性.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
背景情况:
- 设计用于新生儿药物输送的微流体通道需要仔细考虑效率和安全性.
- 优化材料选择和通道几何结构对于有效的新生儿药物管理至关重要.
研究的目的:
- 评估用于微流体新生儿药物输送的高性能材料.
- 通过建模和模拟优化微流体通道设计,以达到0.3-1毫升/小时的目标流速.
主要方法:
- 评估的材料包括PDMS,玻璃,COC,PMMA,PC,TPE和水凝.
- 使用COMSOL多物理进行模拟,分析各种通道几何形状中的流体行为.
- 材料的评估重点是生物相容性 (ISO 10993),机械性能,耐化学物质和易于制造.
主要成果:
- PDMS展示了灵活性和模拟的方便性.
- 来自COMSOL模拟的优化通道设计显示了效率的提高.
- 现在PDMS已经成为新生儿药物输送应用的可行材料.
结论:
- 这项比较研究指导材料和设计选择,以实现更安全,更强大的新生儿微流体药物输送.
- 这些发现支持开发新生儿可靠的药物输送系统.
相关概念视频
Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

